检索结果 - Pujol, Eugènia

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    In Vitro, In Vivo, and Absorption, Distribution, Metabolism, and Excretion Evaluation of SF(5)-Containing N,N’-Diarylureas as Antischistosomal Agents

    In Vitro, In Vivo, and Absorption, Distribution, Metabolism, and Excretion Evaluation of SF(5)-Containing N,N’-Diarylureas as Antischistosomal Agents 由 Probst, Alexandra, Pujol, Eugènia, Häberli, Cécile, Keiser, Jennifer, Vázquez, Santiago

    出版 2021
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  2. 2
    Pentafluorosulfanyl-containing Triclocarban Analogs with Potent Antimicrobial Activity

    Pentafluorosulfanyl-containing Triclocarban Analogs with Potent Antimicrobial Activity 由 Pujol, Eugènia, Blanco-Cabra, Núria, Julián, Esther, Leiva, Rosana, Torrents, Eduard, Vázquez, Santiago

    出版 2018
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  3. 3
    Synthesis, Characterization and HPLC Analysis of the (1S,2S,5R)-Diastereomer and the Enantiomer of the Clinical Candidate AR-15512

    Synthesis, Characterization and HPLC Analysis of the (1S,2S,5R)-Diastereomer and the Enantiomer of the Clinical Candidate AR-15512 由 Rodríguez-Arévalo, Sergio, Pujol, Eugènia, Abás, Sònia, Galdeano, Carles, Escolano, Carmen, Vázquez, Santiago

    出版 2021
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  4. 4
    Oral administration of a new HRI activator as a new strategy to improve high‐fat‐diet‐induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21

    Oral administration of a new HRI activator as a new strategy to improve high‐fat‐diet‐induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21 由 Zarei, Mohammad, Pujol, Eugènia, Quesada‐López, Tania, Villarroya, Francesc, Barroso, Emma, Vázquez, Santiago, Pizarro‐Delgado, Javier, Palomer, Xavier, Vázquez‐Carrera, Manuel

    出版 2019
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  5. 5
    Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer’s Disease

    Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer’s Disease 由 Griñán-Ferré, Christian, Codony, Sandra, Pujol, Eugènia, Yang, Jun, Leiva, Rosana, Escolano, Carmen, Puigoriol-Illamola, Dolors, Companys-Alemany, Júlia, Corpas, Rubén, Sanfeliu, Coral, Pérez, Belen, Loza, M. Isabel, Brea, José, Morisseau, Christophe, Hammock, Bruce D., Vázquez, Santiago, Pallàs, Mercè, Galdeano, Carles

    出版 2020
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  6. 6
    Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease

    Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease 由 Zarei, Mohammad, Barroso, Emma, Palomer, Xavier, Dai, Jianli, Rada, Patricia, Quesada-López, Tania, Escolà-Gil, Joan Carles, Cedó, Lidia, Zali, Mohammad Reza, Molaei, Mahsa, Dabiri, Reza, Vázquez, Santiago, Pujol, Eugènia, Valverde, Ángela M., Villarroya, Francesc, Liu, Yong, Wahli, Walter, Vázquez-Carrera, Manuel

    出版 2017
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  7. 7
    2-Oxaadamant-1-yl ureas as soluble epoxide hydrolase inhibitors: in vivo evaluation in a murine model of acute pancreatitis

    2-Oxaadamant-1-yl ureas as soluble epoxide hydrolase inhibitors: in vivo evaluation in a murine model of acute pancreatitis 由 Codony, Sandra, Pujol, Eugènia, Pizarro, Javier, Feixas, Ferran, Valverde, Elena, Loza, M. Isabel, Brea, José M., Saez, Elena, Oyarzabal, Julen, Pineda-Lucena, Antonio, Pérez, Belén, Pérez, Concepción, Rodríguez-Franco, María Isabel, Leiva, Rosana, Osuna, Sílvia, Morisseau, Christophe, Hammock, Bruce D., Vázquez-Carrera, Manuel, Vázquez, Santiago

    出版 2020
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:

检索工具: